These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31014364)

  • 1. Downregulation of CD73 associates with T cell exhaustion in AML patients.
    Kong Y; Jia B; Zhao C; Claxton DF; Sharma A; Annageldiyev C; Fotos JS; Zeng H; Paulson RF; Prabhu KS; Zheng H
    J Hematol Oncol; 2019 Apr; 12(1):40. PubMed ID: 31014364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of TIGIT
    Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
    Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia.
    Zhu L; Kong Y; Zhang J; Claxton DF; Ehmann WC; Rybka WB; Palmisiano ND; Wang M; Jia B; Bayerl M; Schell TD; Hohl RJ; Zeng H; Zheng H
    J Hematol Oncol; 2017 Jun; 10(1):124. PubMed ID: 28629373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients.
    Kong Y; Zhu L; Schell TD; Zhang J; Claxton DF; Ehmann WC; Rybka WB; George MR; Zeng H; Zheng H
    Clin Cancer Res; 2016 Jun; 22(12):3057-66. PubMed ID: 26763253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of CD73 on B cells of patients with viremic HIV correlates with B cell activation and disease progression.
    Kim ES; Ackermann C; Tóth I; Dierks P; Eberhard JM; Wroblewski R; Scherg F; Geyer M; Schmidt RE; Beisel C; Bockhorn M; Haag F; van Lunzen J; Schulze Zur Wiesch J
    J Leukoc Biol; 2017 May; 101(5):1263-1271. PubMed ID: 28193736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8
    Panigrahi S; Bazdar DA; Albakri M; Ferrari B; Antonelli CJ; Freeman ML; Dubyak G; Zender C; Sieg SF
    Eur J Immunol; 2020 Dec; 50(12):2055-2066. PubMed ID: 32548862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
    Jin D; Fan J; Wang L; Thompson LF; Liu A; Daniel BJ; Shin T; Curiel TJ; Zhang B
    Cancer Res; 2010 Mar; 70(6):2245-55. PubMed ID: 20179192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine.
    Passarelli A; Tucci M; Mannavola F; Felici C; Silvestris F
    Tumour Biol; 2019 Apr; 42(4):1010428319837138. PubMed ID: 30957676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment.
    Neo SY; Yang Y; Record J; Ma R; Chen X; Chen Z; Tobin NP; Blake E; Seitz C; Thomas R; Wagner AK; Andersson J; de Boniface J; Bergh J; Murray S; Alici E; Childs R; Johansson M; Westerberg LS; Haglund F; Hartman J; Lundqvist A
    J Clin Invest; 2020 Mar; 130(3):1185-1198. PubMed ID: 31770109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.
    Zhu Y; Banerjee A; Xie P; Ivanov AA; Uddin A; Jiao Q; Chi JJ; Zeng L; Lee JY; Xue Y; Lu X; Cristofanilli M; Gradishar WJ; Henry CJ; Gillespie TW; Bhave MA; Kalinsky K; Fu H; Bahar I; Zhang B; Wan Y
    J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38530357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific blockade CD73 alters the "exhausted" phenotype of T cells in head and neck squamous cell carcinoma.
    Deng WW; Li YC; Ma SR; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2018 Sep; 143(6):1494-1504. PubMed ID: 29663369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD73 as a potential opportunity for cancer immunotherapy.
    Ghalamfarsa G; Kazemi MH; Raoofi Mohseni S; Masjedi A; Hojjat-Farsangi M; Azizi G; Yousefi M; Jadidi-Niaragh F
    Expert Opin Ther Targets; 2019 Feb; 23(2):127-142. PubMed ID: 30556751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer.
    Chabab G; Barjon C; Abdellaoui N; Salvador-Prince L; Dejou C; Michaud HA; Boissière-Michot F; Lopez-Crapez E; Jacot W; Pourquier D; Bonnefoy N; Lafont V
    J Leukoc Biol; 2020 Jun; 107(6):1057-1067. PubMed ID: 32362028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD73 slows down migration of skin dendritic cells, affecting the sensitization phase of contact hypersensitivity reactions in mice.
    Neuberger A; Ring S; Silva-Vilches C; Schrader J; Enk A; Mahnke K
    J Dermatol Sci; 2017 Sep; 87(3):292-299. PubMed ID: 28743609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory Molecules PD-1, CD73 and CD39 Are Expressed by CD8
    Smith CJ; Snyder CM
    Front Immunol; 2021; 12():704862. PubMed ID: 34335618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecto-enzyme and signaling functions of lymphocyte CD73.
    Resta R; Yamashita Y; Thompson LF
    Immunol Rev; 1998 Feb; 161():95-109. PubMed ID: 9553767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma.
    Tripathi A; Lin E; Xie W; Flaifel A; Steinharter JA; Stern Gatof EN; Bouchard G; Fleischer JH; Martinez-Chanza N; Gray C; Mantia C; Thompson L; Wei XX; Giannakis M; McGregor BA; Choueiri TK; Agarwal N; McDermott DF; Signoretti S; Harshman LC
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33177176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
    Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
    Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome.
    Wang X; Zhang T; Song Z; Li L; Zhang X; Liu J; Liu X; Qiu L; Qian Z; Zhou S; Feng L; Hu G; Meng B; Zhai Q; Ren X; Fu K; Li L; Wang P; Zhang H
    Int J Cancer; 2019 Sep; 145(5):1414-1422. PubMed ID: 30664812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV "elite controllers" are characterized by a high frequency of memory CD8+ CD73+ T cells involved in the antigen-specific CD8+ T-cell response.
    Carrière M; Lacabaratz C; Kök A; Benne C; Jenabian MA; Casartelli N; Hüe S; Hocqueloux L; Lelièvre JD; Lévy Y
    J Infect Dis; 2014 May; 209(9):1321-30. PubMed ID: 24357632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.